Navigate healthcare data sourcing with this enterprise guide covering data types, HIPAA compliance, and provider evaluation.
Healthcare data has become one of the most sought-after data categories for enterprise buyers across industries. From pharmaceutical companies optimizing clinical trial recruitment to insurance carriers refining risk models, healthcare data drives critical business decisions worth billions of dollars annually.
The healthcare data market is projected to exceed $50 billion by 2027, driven by advances in precision medicine, value-based care models, and the digitization of health records. Yet healthcare data also presents unique challenges: strict regulatory requirements, complex data structures, fragmented sources, and heightened sensitivity around patient privacy make healthcare data procurement significantly more complex than other data categories.
Healthcare data spans a broad spectrum from highly regulated patient-level records to aggregated market intelligence, each serving different enterprise use cases.
Claims and billing data captures healthcare utilization patterns through insurance claims records. This data reveals diagnosis frequencies, treatment patterns, prescription volumes, provider utilization, and cost trends across populations. Claims data is the most widely used healthcare data type for market analysis, outcomes research, and healthcare economics studies.
Electronic health record (EHR) data contains clinical observations, lab results, imaging reports, medication histories, and provider notes. De-identified EHR data enables pharmaceutical companies to study real-world treatment patterns, identify undiagnosed patient populations, and support post-market surveillance of drugs and devices.
Prescription and pharmacy data tracks medication dispensing at the pharmacy level, including prescription volumes by drug, prescriber patterns, payer mix, and patient adherence metrics. This data is essential for pharmaceutical commercial teams, pharmacy benefit managers, and healthcare investors.
Genomic and biomarker data represents the frontier of precision medicine data. As genetic testing becomes more mainstream, datasets linking genomic profiles to health outcomes enable drug target discovery, companion diagnostic development, and population health risk stratification.
Social determinants of health (SDOH) data captures non-clinical factors that influence health outcomes: economic stability, education access, food security, housing quality, and community context. SDOH data is increasingly integrated into population health management, care coordination, and health equity initiatives.
Healthcare data procurement operates under the most stringent regulatory framework of any data category. Enterprise buyers must navigate multiple overlapping regulations.
HIPAA (Health Insurance Portability and Accountability Act) governs protected health information (PHI) in the United States. Enterprise buyers typically access healthcare data through two HIPAA-compliant pathways: de-identified datasets (where all 18 HIPAA identifiers have been removed or statistically verified as non-identifiable) or limited datasets under a data use agreement for research purposes.
HITECH Act extends HIPAA requirements to business associates and increases penalties for data breaches. Any organization that receives, maintains, or transmits PHI on behalf of a covered entity must comply with HIPAA security requirements.
State-level health data regulations add additional requirements beyond federal law. States like California, New York, and Texas have specific health data privacy laws that may impose stricter de-identification standards, consent requirements, or breach notification obligations.
International regulations including GDPR, which classifies health data as a special category requiring explicit consent for processing, and country-specific health data laws in markets like the UK, Germany, and Japan.
Given the regulatory complexity and quality variability in healthcare data, enterprise buyers need a structured evaluation framework.
Assess data provenance and consent documentation thoroughly. Understand exactly how the data was collected, what de-identification methodology was applied, and what legal basis supports its commercial distribution. Reputable providers welcome these questions; providers who can't answer them clearly should be avoided.
Validate data quality through sample evaluation. Healthcare data quality issues—coding inconsistencies, missing fields, temporal gaps, and population bias—directly impact analytical conclusions. Request sample datasets and validate against known benchmarks before committing to procurement.
Evaluate the provider's compliance infrastructure. Do they have a dedicated privacy officer? Have they undergone independent HIPAA audits? What is their breach notification process? These operational indicators predict whether the provider will remain a reliable, compliant partner over time.
DataZn's marketplace features vetted healthcare data providers offering claims, clinical, prescription, and SDOH datasets with standardized compliance documentation. Our platform streamlines healthcare data procurement by providing transparent quality metrics, clear licensing terms, and verified regulatory compliance status for every healthcare data product listed.
